Alaethes Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.11M Sell
4,263
-13
-0.3% -$13.3K 1.48% 18
2026
Q1
$3.93M Sell
4,276
-5
-0.1% -$5.07K 1.12% 20
2025
Q4
$4.6M Sell
4,281
-64
-1% -$61.2K 1.3% 16
2025
Q3
$3.32M Sell
4,345
-82
-2% -$61K 0.94% 23
2025
Q2
$3.45M Buy
4,427
+194
+5% +$151K 1.03% 20
2025
Q1
$3.5M Buy
4,233
+148
+4% +$123K 1.28% 14
2024
Q4
$3.15M Buy
4,085
+3,555
+671% +$2.94M 1.13% 19
2024
Q3
$470K Buy
530
+42
+9% +$37.8K 0.17% 93
2024
Q2
$442K Hold
488
0.18% 93
2024
Q1
$380K Sell
488
-95
-16% -$67.6K 0.17% 95
2023
Q4
$340K Sell
583
-323
-36% -$189K 0.16% 96
2023
Q3
$487K Buy
906
+6
+0.7% +$3.09K 0.27% 92
2023
Q2
$422K Buy
900
+70
+8% +$29.4K 0.23% 93
2023
Q1
$285K Buy
830
+89
+12% +$30K 0.17% 100
2022
Q4
$271K Sell
741
-4,553
-86% -$1.61M 0.19% 92
2022
Q3
$1.71M Buy
5,294
+481
+10% +$152K 1.26% 16
2022
Q2
$1.56M Sell
4,813
-254
-5% -$76.2K 1.16% 20
2022
Q1
$1.45M Buy
5,067
+112
+2% +$28.8K 0.92% 30
2021
Q4
$1.37M Buy
4,955
+503
+11% +$128K 0.86% 37
2021
Q3
$1.03M Sell
4,452
-147
-3% -$36.3K 0.75% 53
2021
Q2
$1.06M Buy
4,599
+151
+3% +$30.3K 0.82% 47
2021
Q1
$831K Buy
+4,448
New +$870K 0.77% 50

Other funds holding LLY

Alaethes Wealth's LLY Position: Q2 2026 in Review

Alaethes Wealth reduced its Eli Lilly (LLY) stake by 0.3% in Q2 2026, selling an estimated $13.3K and leaving 4,263 shares worth $5.11M. The position accounts for 1.48% of the portfolio, ranked #18.

Alaethes Wealth first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Alaethes Wealth held 4,263 shares of Eli Lilly worth $5.11M as of Q2 2026.
  • Alaethes Wealth sold 13 Eli Lilly shares in Q2 2026, an estimated $13.3K.
  • Eli Lilly made up 1.48% of Alaethes Wealth's portfolio in Q2 2026, its #18 holding.
  • Alaethes Wealth first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Alaethes Wealth's 13F filing for Q2 2026, filed 14 Aug 2026.